Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ulodesine and allopurinol combined for 12
weeks are effective in treating gout in patients who are not adequately responding to
allopurinol alone.